Skip to content

Clinical trials

Completed Phase 3 Migraine Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Phase: Phase 3 Status: Completed Clear all

167 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20021
20038
200412
20059
200613
20079
20086
20097
20102
20111
20125
20131
20159
201612
20178
20185
201913
20209
20216
202211
20236
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed167

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline13
Organon and Co13
Pfizer11
Allergan10
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.9
Eli Lilly and Company7
Teva Branded Pharmaceutical Products R&D, Inc.6
AbbVie5
H. Lundbeck A/S5
Merck Sharp & Dohme LLC5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders167
Headache40
Migraine without Aura9
Migraine with Aura8
Bronchiolitis Obliterans Syndrome5
Epilepsy5
Headache Disorders3
Pain3
Tension-Type Headache3
Dysmenorrhea2

Trials

Showing 1 to 25 of 167. Each trial links to its page on Pharma Observatory.

67 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.